IT1258182B - Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori - Google Patents

Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori

Info

Publication number
IT1258182B
IT1258182B ITFI920167A ITFI920167A IT1258182B IT 1258182 B IT1258182 B IT 1258182B IT FI920167 A ITFI920167 A IT FI920167A IT FI920167 A ITFI920167 A IT FI920167A IT 1258182 B IT1258182 B IT 1258182B
Authority
IT
Italy
Prior art keywords
vacuolization
compositions containing
helicobacter pylori
bafilomycina
inhibition induced
Prior art date
Application number
ITFI920167A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITFI920167A priority Critical patent/IT1258182B/it
Publication of ITFI920167A0 publication Critical patent/ITFI920167A0/it
Priority to EP93917786A priority patent/EP0654999A1/en
Priority to CA002142313A priority patent/CA2142313A1/en
Priority to JP6505871A priority patent/JPH08502725A/ja
Priority to PCT/EP1993/002149 priority patent/WO1994004161A1/en
Priority to AU47095/93A priority patent/AU4709593A/en
Publication of ITFI920167A1 publication Critical patent/ITFI920167A1/it
Application granted granted Critical
Publication of IT1258182B publication Critical patent/IT1258182B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)

Abstract

Sono descritte composizioni contenenti bafilomycina capaci di inibire la vacuolizzazione cellulare indotto da Helicobacter pylori.
ITFI920167A 1992-08-12 1992-08-12 Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori IT1258182B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI920167A IT1258182B (it) 1992-08-12 1992-08-12 Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori
EP93917786A EP0654999A1 (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type h?+ atpases
CA002142313A CA2142313A1 (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type h atpases
JP6505871A JPH08502725A (ja) 1992-08-12 1993-08-11 液胞型ｈ▲上＋▼ａｔｐアーゼのインヒビターの使用
PCT/EP1993/002149 WO1994004161A1 (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type h+ atpases
AU47095/93A AU4709593A (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type H+ atpases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920167A IT1258182B (it) 1992-08-12 1992-08-12 Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori

Publications (3)

Publication Number Publication Date
ITFI920167A0 ITFI920167A0 (it) 1992-08-12
ITFI920167A1 ITFI920167A1 (it) 1994-02-12
IT1258182B true IT1258182B (it) 1996-02-20

Family

ID=11350200

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920167A IT1258182B (it) 1992-08-12 1992-08-12 Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori

Country Status (6)

Country Link
EP (1) EP0654999A1 (it)
JP (1) JPH08502725A (it)
AU (1) AU4709593A (it)
CA (1) CA2142313A1 (it)
IT (1) IT1258182B (it)
WO (1) WO1994004161A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2117490C (en) * 1992-02-26 2009-01-06 Timothy L. Cover Purified vacuolating toxin from helicobacter pylori and methods to use same
US5859219A (en) * 1992-02-26 1999-01-12 Vanderbilt University Purified vacuolating toxin from Helicobacter pylori and methods to use same
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
DE4442970A1 (de) * 1994-12-02 1996-06-05 Byk Gulden Lomberg Chem Fab Screening-Modell
WO1996017066A1 (de) * 1994-12-02 1996-06-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Screening-modell
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
CN113286582B (zh) * 2019-01-18 2025-01-10 国立研究开发法人科学技术振兴机构 V－ATPase活性抑制剂、抗菌剂、药物以及抗菌方法和筛选方法

Also Published As

Publication number Publication date
ITFI920167A1 (it) 1994-02-12
EP0654999A1 (en) 1995-05-31
WO1994004161A1 (en) 1994-03-03
CA2142313A1 (en) 1994-03-03
ITFI920167A0 (it) 1992-08-12
AU4709593A (en) 1994-03-15
JPH08502725A (ja) 1996-03-26

Similar Documents

Publication Publication Date Title
DE69408460D1 (de) Hochreine fluorelastomerzusammensetzungen
GR1002038B (en) Laparascopic instrument for the application of endoligatures.
HU9302762D0 (en) N-sulfonyl-2-oxoindole derivatives being effective on vasopressin and/or oxitocin receptors
IL129768A0 (en) Antithrombotic organic nitrates
IL111314A (en) Pharmaceutical compositions containing indole derivatives
GB9225659D0 (en) Stabilized pharmaceutical compositions comprising an hmg-coa-reductase inhibitor compound
DE69413237D1 (en) Plättchenaggregationsinhibitoren
ZA975727B (en) Inhibitors of prenyl transferases.
DK537389D0 (da) Glycosidase-inhibitoren salbostatin, dens fremstilling og anvendelse
FI943817A7 (fi) Bisyklo/2.2.2/oktaanijohdannaisia kolestokystokiniinin inhibiittoreina
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
JO1704B1 (en) New potent compounds
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
IT1258182B (it) Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori
HU9400726D0 (en) Film-forming compositions containing iodo-phenoxy-alkylen-ether derivatives for visualizing the gastrointes tinal tract
AP9400632A0 (en) Ether derivatives.
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
ITTO910541A0 (it) Rivestimento impermeabilizzante, particolarmente per l'eliminazione diinfiltrazioni
GB8814422D0 (en) Analgesic compounds & compositions
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
IL98405A0 (en) Pharmaceutical compositions containing enzyme inhibiting agents
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
AU2358592A (en) Regioselective synthesis of 1,5-diarylpyrazole anti-inflammatory agents
GB2283677B (en) Liquid anthelmintic selenium compositions

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970827